PROM1 and melanoma: Bostad and coworkers took advantage of the PCI technology by employing a photosensitizer that induces endosomal disruption and subsequent endosomal escape of internalized anticancer drugs, to investigate the potential of AC133-saporin for targeting the CD133+ population of melanoma cells.